Drug intelligence / Profile preview

Cavit-XT

Development stage
Unknown
Lead developer
Cachet Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Cavit-XT is a multi-ingredient nutritional supplement and pharmaceutical formulation developed and marketed by Cachet Pharmaceuticals, a subsidiary of Alkem Laboratories. It is designed to treat and prevent nutritional deficiencies, particularly those affecting bone health and neurological function. The formulation is a combination tablet containing Calcium Carbonate, Vitamin D3 (Cholecalciferol), Methylcobalamin (Vitamin B12), L-Methylfolate Calcium (Vitamin B9), and Pyridoxal-5-phosphate (Vitamin B6). It is commonly prescribed for patients with low blood calcium levels, osteoporosis, or conditions where dietary intake is insufficient to meet the body's requirements for these essential vitamins and minerals. The components work synergistically to support bone density, intestinal calcium absorption, and healthy homocysteine metabolism.

Brand names
Cavit-XT
02

Targets

VDR (Vitamin D receptor)MTR (Methionine synthase)MTHFR (Methylenetetrahydrofolate reductase)

Beyond the preview

Go deeper on Cavit-XT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cavit-XT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call